Prospective phase IIA multicenter double-blinded randomized placebo-controlled clinical trial evaluating the efficacy and safety of inhaled, aerosolized Tobramycin (TOBI) b.i.d. in patients with ventilator-associated pneumonia (VAP)

Trial Profile

Prospective phase IIA multicenter double-blinded randomized placebo-controlled clinical trial evaluating the efficacy and safety of inhaled, aerosolized Tobramycin (TOBI) b.i.d. in patients with ventilator-associated pneumonia (VAP)

Recruiting
Phase of Trial: Phase II

Latest Information Update: 02 Dec 2016

At a glance

  • Drugs Tobramycin (Primary)
  • Indications Nosocomial pneumonia
  • Focus Therapeutic Use
  • Acronyms iTO-VAP
  • Most Recent Events

    • 27 Dec 2014 Planned number of patients changed from 90 to 28 as reported by European Clinical Trials Database record.
    • 17 Oct 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top